IndiaOne Finance - Company Dashboard

Governance Classic Home

Windlas Biotech LtdPharmaceuticalsINE0H5O01029Standalone₹1107.10-10.45 (-0.94%)Jun-26

Valuation

Market Cap₹2.29K Cr

TTM PE35.08x

Forward PE35.94x

PEG389.78

Book Value₹281.47

P/B3.94x

TTM EPS₹31.63

Fwd EPS₹30.87

TTM Revenue₹942.10 Cr

TTM PAT₹66.42 Cr

TTM EBITDA₹104.86 Cr

TTM EBIT₹74.35 Cr

Last Qtr PAT₹17.65 Cr

Last Qtr EBITDA₹26.68 Cr

Last Qtr EBIT₹19.47 Cr

Profitability

ROE11.44%

ROCE15.00%

TTM NPM7.05%

TTM EBITDA %11.13%

Curr OPM6.97%

Last OPM6.60%

Curr NPM—

Last NPM—

Curr EPS₹8.46

Last EPS₹7.60

Balance sheet

Equity₹10.55 Cr

Reserve₹570.29 Cr

Total Debt₹29.88 Cr

D/E0.05x

Interest %9.35%

Curr Interest₹1.65 Cr

Price / range

Close₹1109.45

vs 52W High-5.56%

vs 52W Low+58.64%

MA50—

MA200—

Returns

1D-0.73%

1W-2.60%

1M+20.68%

3M+36.97%

6M+51.19%

1Y+16.09%

2Y+27.41%

3Y+209.86%

5Y—

Diwali+38.52%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	248.10+18.1%	238.50	233.10	222.40	210.09	904.09
Other Income	5.11	4.40	4.52	3.65	5.24	17.80
Total Income	253.21+17.6%	242.90	237.62	226.04	215.33	921.89
Interest	1.65	1.48	1.28	1.02	1.06	4.83
Expenditure	-230.28-19.9%	-222.74	-217.70	-202.46	-192.07	-834.96
PBDT	0	0	0	0	0	0
EBITDA	26.68+0.6%	25.24	24.38	28.56	26.53	104.70
Depreciation	-7.21	-8	-7.70	-7.60	-7.45	-30.74
EBIT	19.47+2.0%	17.24	16.68	20.96	19.08	73.96
PBT	22.94-1.4%	20.16	19.92	23.59	23.26	86.93
Tax	-5.28	-4.15	-4.97	-5.79	-5.59	-20.50
Equity	10.32	10.55	0	0	10.48	10.55
OPM	9.06	8.30	8.55	10.61	10.80	9.43
Net Profit	17.65-0.1%	16.02	14.95	17.80	17.67	66.44
NPM	6.97	6.60	6.42	8.00	8.21	7.21
EPS	8.46+0.4%	7.60	7.09	8.48	8.43	31.59

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	904.09+19.0%	759.88+20.4%	630.96+23.0%	513.08
Other Income	17.80	17.65	13.47	9.97
Total Income	921.89+18.6%	777.52+20.7%	644.42+23.2%	523.05
Expenditure	-834.96-19.6%	-698.13-23.0%	-567.40-21.8%	-465.99
Interest	-4.83	-4.38	-1.10	-0.79
PBDT	0	0	0	0
EBITDA	104.70+11.2%	94.12+20.5%	78.10+29.6%	60.24
Depreciation	-30.74	-27.99	-13.44	-12.36
EBIT	73.96+11.8%	66.13+2.3%	64.66+35.0%	47.88
PBT	86.93+9.5%	79.39+3.1%	77.02+35.0%	57.06
Tax	-20.50	-18.75	-18.88	-14.41
Equity	10.55	10.48	0	0
OPM (%)	9.43	10.21	12.00	11.00
Net Profit	66.44+9.5%	60.65+4.3%	58.14+36.4%	42.64
NPM (%)	7.21	7.80	9.00	8.00
EPS (Rs)	31.59+8.8%	29.03+3.9%	27.95+41.8%	19.71
CEPS	31.14	28.71	27.86	19.71

Metric	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	FY25-26
Revenue	238.50+17.7%	233.10	222.40	210.09	202.71	904.09
Other Income	4.35	4.57	3.65	5.24	4.94	17.80
Total Income	242.85+17.0%	237.67	226.04	215.33	207.64	921.89
Interest	1.48	0	1.02	1.06	1.33	4.83
Expenditure	-222.69-19.2%	-217.70	-202.46	-192.07	-186.82	-834.92
PBDT	0	0	0	0	0	0
EBITDA	25.29-1.1%	15.40	28.56	26.53	25.56	104.74
Depreciation	-8	0	-7.60	-7.45	-8.34	-30.74
EBIT	17.29+0.4%	15.40	20.96	19.08	17.22	74
PBT	20.16-3.2%	19.97	23.59	23.26	20.82	86.98
Tax	-4.17	-4.97	-5.79	-5.59	-4.54	-20.52
Equity	10.55	0	0	10.48	10.48	10.55
OPM	8.30	8.40	10.44	10.80	10.03	9.43
Net Profit	15.99-1.8%	15	17.80	17.66	16.28	66.46
NPM	6.58	6.31	7.87	8.20	7.84	7.21
EPS	7.58-2.4%	0	8.48	8.43	7.77	31.60

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	904.09+19.0%	759.88+20.4%	630.96+23.0%	513.08
Other Income	17.80	18.02	13.47	9.97
Total Income	921.89+18.5%	777.90+20.7%	644.42+23.2%	523.05
Expenditure	-834.92-19.6%	-698.14-23.1%	-567.33-21.7%	-466.01
Interest	-4.83	-4.38	-1.11	-0.79
PBDT	0	0	0	0
EBITDA	104.74+11.3%	94.11+20.4%	78.18+29.8%	60.22
Depreciation	-30.74	-27.99	-13.44	-12.36
EBIT	74+11.9%	66.12+2.1%	64.74+35.3%	47.86
PBT	86.98+9.1%	79.76+3.5%	77.09+35.2%	57.04
Tax	-20.52	-18.76	-18.90	-14.41
Equity	10.55	10.48	0	0
OPM (%)	9.43	10.25	11.96	10.91
Net Profit	66.46+9.0%	60.99+4.8%	58.19+36.5%	42.63
NPM (%)	7.21	7.84	9.03	8.15
EPS (Rs)	31.60+8.3%	29.19+4.4%	27.97+42.0%	19.70
CEPS	31.15	28.87	27.88	19.70

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	6.3	16 Jul 2026
2025	Final Dividend	5.8	21 Jul 2025
2024	Final Dividend	5.5	17 Sep 2024
2023	Final Dividend	4	05 Sep 2023

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split